NCT03574103

Brief Summary

The aim of the study is to determine if time-restricted feeding (TRF) is an effective dietary strategy to weight loss after 8 weeks intervention. TRF will be compared with an intervention without restriction in time for feeding. Both strategies will be with caloric restriction.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
4mo left

Started Jul 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress96%
Jul 2018Dec 2026

First Submitted

Initial submission to the registry

June 19, 2018

Completed
10 days until next milestone

First Posted

Study publicly available on registry

June 29, 2018

Completed
10 days until next milestone

Study Start

First participant enrolled

July 9, 2018

Completed
7.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2025

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Expected
Last Updated

March 18, 2025

Status Verified

March 1, 2025

Enrollment Period

7.2 years

First QC Date

June 19, 2018

Last Update Submit

March 14, 2025

Conditions

Keywords

ObesityOverweightWeight lossFasting

Outcome Measures

Primary Outcomes (1)

  • Change in body weight

    Body weight will be assessed by mechanical scale

    Baseline and weeks 2, 4 and 8

Secondary Outcomes (9)

  • Change in body composition

    Baseline and weeks 2, 4 and 8

  • Change in resting energy expenditure

    Baseline and weeks 2, 4 and 8

  • Change in self-reported energy intake

    Baseline and weeks 2, 4 and 8

  • Change in self-reported diet composition

    Baseline and weeks 2, 4 and 8

  • Change in self-reported intervention adherence

    Baseline and weeks 2, 4 and 8

  • +4 more secondary outcomes

Other Outcomes (5)

  • High-sensitivity C-reactive protein

    Baseline and weeks 2, 4 and 8

  • Insulin

    Baseline and weeks 2, 4 and 8

  • Leptin

    Baseline and weeks 2, 4 and 8

  • +2 more other outcomes

Study Arms (3)

Caloric restriction only

ACTIVE COMPARATOR

Participants in this group will receive a eating plan with caloric restriction as dietary weight loss strategy.

Behavioral: Caloric restriction only

Caloric restriction plus TRF morning

EXPERIMENTAL

Participants in this group will receive a eating plan with caloric and time restriction as dietary weight loss strategy.

Behavioral: Caloric restriction plus TRF morning

Caloric restriction plus TRF night

EXPERIMENTAL

Participants in this group will receive a eating plan with caloric and time restriction as dietary weight loss strategy.

Behavioral: Caloric restriction plus TRF night

Interventions

Participants in this group will receive a eating plan with caloric restriction (513 to 770 kcal from estimated energy requirements), without restriction in time for feeding, for 8 weeks.

Caloric restriction only

Participants in this group will receive a eating plan with caloric restriction (513 to 770 kcal from estimated energy requirements) and 8 hours for eating (from 12 p.m. to 8 p.m.) and 16 hours of fasting, for 8 weeks.

Caloric restriction plus TRF morning

Participants in this group will receive a eating plan with caloric restriction (513 to 770 kcal from estimated energy requirements) and 8 hours for eating (from 8 a.m. to 4 p.m.) and 16 hours of fasting, for 8 weeks.

Caloric restriction plus TRF night

Eligibility Criteria

Age18 Years - 59 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Females;
  • Aged between 18 and 59 years old;
  • Body mass index equal or greater 25 kg/m²;
  • Agree to sign the informed consent.

You may not qualify if:

  • Any chronic health conditions (e.g. chronic renal failure, autoimmune, heart, and liver disease);
  • Thyroid diseases or medications for its treatment;
  • Medications known to affect total energy expenditure;
  • Use of steroids, immunosuppressants or non-steroidal anti-inflammatory drugs, weight-loss medications, oral hypoglycemic agents or insulin and any medications that influence metabolic and/or inflammatory parameters;
  • Previous surgery for weight loss;
  • Pregnancy or breast-feeding;
  • Smoking;
  • Alcohol use (\>2 doses/day).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Hospital da Clínicas

Belo Horizonte, Minas Gerais, 30130-100, Brazil

RECRUITING

Hospital das Clínicas

Belo Horizonte, Minas Gerais, 30130-100, Brazil

RECRUITING

Related Publications (1)

  • Allaf M, Elghazaly H, Mohamed OG, Fareen MFK, Zaman S, Salmasi AM, Tsilidis K, Dehghan A. Intermittent fasting for the prevention of cardiovascular disease. Cochrane Database Syst Rev. 2021 Jan 29;1(1):CD013496. doi: 10.1002/14651858.CD013496.pub2.

MeSH Terms

Conditions

OverweightObesityWeight LossFasting

Interventions

Caloric Restriction

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBody Weight ChangesFeeding BehaviorBehavior

Intervention Hierarchy (Ancestors)

Diet TherapyNutrition TherapyTherapeuticsEnergy IntakeDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Central Study Contacts

Adaliene VM Ferreira, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

June 19, 2018

First Posted

June 29, 2018

Study Start

July 9, 2018

Primary Completion

September 1, 2025

Study Completion (Estimated)

December 1, 2026

Last Updated

March 18, 2025

Record last verified: 2025-03

Locations